Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T S Lawrence

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 10, 1997
A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastasesJ M Robertson, C J McGinn, S Walker, et al.
Gene Therapy|June 25, 2002
The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer modelM K Nyati, Z Symon, E Kievit, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 1999
Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopyL D Stegman, A Rehemtulla, B Beattie, et al.
Cancer Research|April 15, 1994
Clinical pharmacology of hepatic arterial infusions of 5-bromo-2'-deoxyuridineW D Ensminger, S C Walker, P L Stetson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathwaysZ Ding, R E Parchment, P M LoRusso, et al.
Cell Death and Differentiation|June 26, 2010
A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulumJ Lian, X Wu, F He, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1993
Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant gliomaP W McLaughlin, W R Mancini, P L Stetson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
The reproducibility of organ position using active breathing control (ABC) during liver radiotherapyL A Dawson, K K Brock, S Kazanjian, et al.
Cancer Research|September 1, 1995
Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusionJ A Knol, S C Walker, J M Robertson, et al.
Cancer Research|July 1, 1992
The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancerT S Lawrence, M A Davis, J Maybaum, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|December 10, 1997
A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastasesJ M Robertson, C J McGinn, S Walker, et al.
Gene Therapy|June 25, 2002
The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer modelM K Nyati, Z Symon, E Kievit, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 1999
Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopyL D Stegman, A Rehemtulla, B Beattie, et al.
Cancer Research|April 15, 1994
Clinical pharmacology of hepatic arterial infusions of 5-bromo-2'-deoxyuridineW D Ensminger, S C Walker, P L Stetson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathwaysZ Ding, R E Parchment, P M LoRusso, et al.
Cell Death and Differentiation|June 26, 2010
A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulumJ Lian, X Wu, F He, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1993
Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant gliomaP W McLaughlin, W R Mancini, P L Stetson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
The reproducibility of organ position using active breathing control (ABC) during liver radiotherapyL A Dawson, K K Brock, S Kazanjian, et al.
Cancer Research|September 1, 1995
Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusionJ A Knol, S C Walker, J M Robertson, et al.
Cancer Research|July 1, 1992
The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancerT S Lawrence, M A Davis, J Maybaum, et al.
Pageof 14